Cite
HARVARD Citation
Scheckel, C. et al. (2020). Efficacy of mitoxantrone-based salvage therapies in relapsed or refractory acute myeloid leukemia in the Mayo Clinic Cancer Center: Analysis of survival after 'CLAG-M' vs. 'MEC'. Leukemia research. p. . [Online].